Michael J Gonzalez to DNA Mutational Analysis
This is a "connection" page, showing publications Michael J Gonzalez has written about DNA Mutational Analysis.
Connection Strength
0.124
-
Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, Pinder SE, Laskey RA, Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004 Oct; 204(2):121-30.
Score: 0.061
-
Strickland AV, Schabh?ttl M, Offenbacher H, Synofzik M, Hauser NS, Brunner-Krainz M, Gruber-Sedlmayr U, Moore SA, Windhager R, Bender B, Harms M, Klebe S, Young P, Kennerson M, Garcia AS, Gonzalez MA, Z?chner S, Schule R, Shy ME, Auer-Grumbach M. Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1. J Neurol. 2015 Sep; 262(9):2124-34.
Score: 0.032
-
Griffin LB, Sakaguchi R, McGuigan D, Gonzalez MA, Searby C, Z?chner S, Hou YM, Antonellis A. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Hum Mutat. 2014 Nov; 35(11):1363-71.
Score: 0.031